Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sergio A. Giralt"'
Autor:
Roni, Shouval, Ana, Alarcon Tomas, Joshua A, Fein, Jessica R, Flynn, Ettai, Markovits, Shimrit, Mayer, Aishat, Olaide Afuye, Anna, Alperovich, Theodora, Anagnostou, Michal J, Besser, Connie Lee, Batlevi, Parastoo B, Dahi, Sean M, Devlin, Warren B, Fingrut, Sergio A, Giralt, Richard J, Lin, Gal, Markel, Gilles, Salles, Craig S, Sauter, Michael, Scordo, Gunjan L, Shah, Nishi, Shah, Ruth, Scherz-Shouval, Marcel, van den Brink, Miguel-Angel, Perales, Maria Lia, Palomba
Publikováno v:
J Clin Oncol
Tumor-intrinsic features may render large B-cell lymphoma (LBCL) insensitive to CD19-directed chimeric antigen receptor T cells (CAR-T). We hypothesized that TP53 genomic alterations are detrimental to response outcomes in LBCL treated with CD19-CAR-
Autor:
Sham Mailankody, Sean M. Devlin, Jonathan Landa, Karthik Nath, Claudia Diamonte, Elizabeth J. Carstens, Douglas Russo, Romany Auclair, Lisa Fitzgerald, Briana Cadzin, Xiuyan Wang, Devanjan Sikder, Brigitte Senechal, Vladimir P. Bermudez, Terence J. Purdon, Kinga Hosszu, Devin P. McAvoy, Tasmin Farzana, Elena Mead, Jessica A. Wilcox, Bianca D. Santomasso, Gunjan L. Shah, Urvi A. Shah, Neha Korde, Alexander Lesokhin, Carlyn R. Tan, Malin Hultcrantz, Hani Hassoun, Mikhail Roshal, Filiz Sen, Ahmet Dogan, Ola Landgren, Sergio A. Giralt, Jae H. Park, Saad Z. Usmani, Isabelle Rivière, Renier J. Brentjens, Eric L. Smith
Publikováno v:
N Engl J Med
BACKGROUND: B-cell maturation antigen (BCMA)–directed chimeric antigen receptor (CAR) T-cell therapies have generated responses in patients with advanced myeloma, but relapses are common. G protein–coupled receptor, class C, group 5, member D (GP
Autor:
Karthik Nath, Ana Alarcon Tomas, Jessica Flynn, Joshua A. Fein, Anna Alperovich, Theodora Anagnostou, Connie Lee Batlevi, Parastoo B. Dahi, Warren B. Fingrut, Sergio A. Giralt, Richard J. Lin, M. Lia Palomba, Jonathan U. Peled, Gilles Salles, Craig S. Sauter, Michael Scordo, Ellen Fraint, Elise Feuer, Nishi Shah, John B. Slingerland, Sean Devlin, Gunjan L. Shah, Gaurav Gupta, Miguel-Angel Perales, Roni Shouval
Publikováno v:
Transplantation and Cellular Therapy. 28:751.e1-751.e7
Vitamin D insufficiency is a potentially modifiable risk factor for poor outcomes in newly diagnosed large B-cell lymphoma (LBCL). However, the role of circulating vitamin D concentrations in relapsed/refractory LBCL treated with CD19-directed chimer